Starbucks China responded to the new Chief Growth Officer: promoting the sustainable development of Starbucks brand in China. Recently, some media reported that the management of Starbucks China continued to adjust and hired CGO to manage the growth from digital marketing companies. In response to the above information, Sina Technology verified Starbucks, and the official response said: China is Starbucks' largest international market and an important engine for the company's future growth. In November, Starbucks China established the Chief Growth Officer (CGO) organization and appointed Tony Yang as the company's Chief Growth Officer (CGO). The establishment of CGO organization will continue to strengthen Starbucks' coffee leadership, accelerate the product innovation with coffee as the core, better refresh customers' Starbucks experience at various contacts through integrated marketing strategies, and promote the sustainable development of Starbucks brand in China. (Sina Technology)State Railway Administration: From January to November, the national railway passenger volume reached a record high, and the State Railway Administration announced that from January to November, the national railway passenger volume reached a record high. From January to November, the number of railway passengers sent nationwide reached 4.015 billion, up 12.6% year-on-year, and the annual number of passengers sent exceeded 4 billion for the first time, reaching a record high. Passenger turnover reached 1,484.061 billion person-kilometers, a year-on-year increase of 7.8%. In the month of November, the number of railway passengers sent nationwide was 304 million, up 8.8% year-on-year; Passenger turnover reached 98.135 billion person-kilometers, a year-on-year increase of 2.5%. The volume of freight delivery has increased steadily. From January to November, the national railway freight volume was 4.715 billion tons, a year-on-year increase of 2.5%. In November, the national railway freight volume was 455 million tons, a year-on-year increase of 6.4%; The freight turnover was 324.521 billion tons kilometers, up 2.4% year-on-year.Offcn Education has set up a new company in Hainan with digital technology services. According to the enterprise survey APP, recently, Hainan Offcn Zhiyuan Education Technology Co., Ltd. was established, with Li Delin as the legal representative and a registered capital of 1 million yuan. Its business scope includes: enrollment assistance services; Digital technology services, etc. Enterprise survey shows that the company is indirectly wholly-owned by Zhonggong Education.
Pan American Health Organization (PAHO): The number of cases of dengue fever in America exceeded 12.6 million this year. On the 10th, PAHO reported that the number of cases of dengue fever reported in America this year reached a record of more than 12.6 million, including 21,000 severe cases and over 7,700 deaths. According to a statement issued by the Pan-American Health Organization on the same day, this year, the most serious dengue fever epidemic broke out in the Americas since records began in 1980. The impact of this epidemic on Brazil, Argentina, Colombia and Mexico is particularly serious. These four countries account for 90% of the total number of cases and 88% of the total number of deaths in this region.The New Zealand dollar fell to $0.57885, the lowest since October 2023.Gold prices rose three times in a row, and brands such as Chow Tai Fook and Lao Fengxiang broke through 810 yuan. After a short-term shock, the gold trend became stronger. On December 11th, spot gold hit $2,700 per ounce, hitting a two-week high and rising for three consecutive days. As of press time, COMEX Gold reported $2,737.5 per ounce, up 0.7% in the day. In the domestic gold consumption market, the gold prices of gold brands such as Chow Tai Fook, Lao Fengxiang and Luk Fook Jewelry reached 812 yuan/gram, while the gold prices in Zhou Shengsheng reached 814 yuan/gram. (Dahe Finance Cube)
President of Japan Life Insurance: I don't think we are behind our competitors in overseas acquisitions, but we are concerned about different countries.Five members of South Korea's ruling party supported the impeachment of Yin Xiyue. Kim Jae-sub, a member of South Korea's ruling National Power Party, announced through live television that he would no longer abide by the ruling party's position of opposing the impeachment of President Yin Xiyue and would vote in favor of the next presidential impeachment case. At present, five members of South Korea's ruling party have indicated that they will support the impeachment of President Yin Xiyue. There are 300 seats in South Korea's National Assembly, and the impeachment case of the President must obtain at least 2/3, that is, at least 200 members vote in favor before it can pass the National Assembly and enter the trial stage of the Korean Constitutional Court. At present, South Korea's parliament, including the largest opposition party, the Common Democratic Party, has 192 seats in the opposition camp and 108 seats in the ruling party. On the premise that all members of the opposition camp voted for impeachment, only eight members of the ruling party voted for it, and Yin Xiyue's impeachment case will pass the parliament. At present, three members of parliament from the ruling party need to vote for impeachment. (CCTV International News)Academician Qiao Jie, Executive Vice President of Peking University, and his party visited Sunflower Pharmaceutical Group. On December 9th, Academician Qiao Jie, Executive Vice President of Peking University, and his party visited the headquarters of Sunflower Pharmaceutical Group for investigation and exchange. At the symposium, Tan Lei, general manager of the strategic management department of Sunflower Pharmaceutical Group, gave a detailed report on the promotion plan of the project "Peking University Medical-Sunflower Pharmaceutical Group Joint Laboratory of Bacterial Enzyme and Innovative Drugs". Sunflower Pharmaceutical Group will join hands with Peking University Medical Center, and the teams of the two sides will cooperate in depth to jointly develop new drugs based on the active substances of traditional Chinese medicine and the discovered important disease targets, promote the transformation of scientific research achievements, deepen the advantageous fields of biotechnology, and help improve the scientific research and innovation ability and technology development level. During the talks, the two sides also conducted in-depth exchanges and discussions on a number of contents.
Strategy guide
12-13
Strategy guide 12-13
Strategy guide 12-13
Strategy guide 12-13